Azienda Ospedaliero-Universitaria Careggi-ko ikertzaileekin lankidetzan egindako argitalpenak (21)

2023

  1. Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation

    Haematologica

  2. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

    The Lancet, Vol. 401, Núm. 10373, pp. 269-280

2022

  1. Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series

    Journal of Crohn's and Colitis, Vol. 16, Núm. 6, pp. 940-945

2021

  1. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

    ESC Heart Failure, Vol. 8, Núm. 1, pp. 95-105

  2. Genome-wide association study identifies novel susceptibility loci for KIT D816V positive mastocytosis

    American Journal of Human Genetics, Vol. 108, Núm. 2, pp. 284-294

2020

  1. Characteristics of Early Paget's Disease in SQSTM1 Mutation Carriers: Baseline Analysis of the ZiPP Study Cohort

    Journal of Bone and Mineral Research, Vol. 35, Núm. 7, pp. 1246-1252

  2. Left atrial appendage occlusion for stroke despite oral anticoagulation (resistant stroke). Results from the Amplatzer Cardiac Plug registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 1, pp. 28-34

2019

  1. Zoledronate in the prevention of Paget's (ZiPP): Protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget's disease of bone

    BMJ Open, Vol. 9, Núm. 9

2017

  1. Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis

    American Heart Journal, Vol. 193, pp. 46-54

  2. Incidence and Clinical Impact of Device-Associated Thrombus and Peri-Device Leak Following Left Atrial Appendage Closure With the Amplatzer Cardiac Plug

    JACC: Cardiovascular Interventions, Vol. 10, Núm. 4, pp. 391-399

  3. Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Previous Major Gastrointestinal Bleeding (from the Amplatzer Cardiac Plug Multicenter Registry)

    American Journal of Cardiology, Vol. 120, Núm. 3, pp. 414-420

  4. Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation

    Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380

  5. Patients with intracranial bleeding and atrial fibrillation treated with left atrial appendage occlusion: Results from the Amplatzer Cardiac Plug registry

    International Journal of Cardiology, Vol. 236, pp. 232-236

2016

  1. Characterization of Cerebrovascular Events After Left Atrial Appendage Occlusion

    American Journal of Cardiology, Vol. 118, Núm. 12, pp. 1836-1841

  2. Comparison of Efficacy and Safety of Left Atrial Appendage Occlusion in Patients Aged <75 to ≥75 Years

    American Journal of Cardiology, Vol. 117, Núm. 1, pp. 84-90

  3. Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation

    International Journal of Cardiology, Vol. 207, pp. 335-340

  4. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: Multicentre experience with the AMPLATZER Cardiac Plug

    EuroIntervention, Vol. 11, Núm. 10, pp. 1170-1179

2012

  1. High-Dose Therapy and Autologous Stem Cell Transplantation in First Relapse for Diffuse Large B Cell Lymphoma in the Rituximab Era: An Analysis Based on Data from the European Blood and Marrow Transplantation Registry

    Biology of Blood and Marrow Transplantation, Vol. 18, Núm. 5, pp. 788-793

2009

  1. Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: Identification of prognostic factors predicting outcome

    Haematologica, Vol. 94, Núm. 2, pp. 230-238

2003

  1. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow

    Blood, Vol. 102, Núm. 8, pp. 3043-3051